Gastroduodenal, Intestinal and Colonic Permeability during Anticancer Therapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F11%3A10223936" target="_blank" >RIV/61989592:15110/11:10223936 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/11:10110325 RIV/00179906:_____/11:10110325
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Gastroduodenal, Intestinal and Colonic Permeability during Anticancer Therapy
Original language description
Measurement of the permeability of gut mucosa may offer a method for objective assessment of mucosal dysfunction during cancer therapy. Methodology: Gastroduodenal, intestinal and colonic permeability was studied by using capillary gas chromatography andmeasuring urinary sucralose, sucrose, lactulose, xylose and mannitol levels. A total of 41 patients with metastatic colorectal carcinoma or epithelial ovarian carcinoma were studied before and during chemotherapy with the combinations of cetuximab, irinotecan, 5-fluorouracil and leucovorin; bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin; or paclitaxel/platinum
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Hepato-Gastroenterology
ISSN
0172-6390
e-ISSN
—
Volume of the periodical
58
Issue of the periodical within the volume
109
Country of publishing house
GR - GREECE
Number of pages
7
Pages from-to
1193-1199
UT code for WoS article
—
EID of the result in the Scopus database
—